首页> 外文期刊>Pharmacological reviews >Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery.
【24h】

Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery.

机译:七个跨膜受体作为变形蛋白:变构调节和功能选择性对新药发现的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

It is useful to consider seven transmembrane receptors (7TMRs) as disordered proteins able to allosterically respond to a number of binding partners. Considering 7TMRs as allosteric systems, affinity and efficacy can be thought of in terms of energy flow between a modulator, conduit (the receptor protein), and a number of guests. These guests can be other molecules, receptors, membrane-bound proteins, or signaling proteins in the cytosol. These vectorial flows of energy can yield standard canonical guest allostery (allosteric modification of drug effect), effects along the plane of the cell membrane (receptor oligomerization), or effects directed into the cytosol (differential signaling as functional selectivity). This review discusses these apparently diverse pharmacological effects in terms of molecular dynamics and protein ensemble theory, which tends to unify 7TMR behavior toward cells. Special consideration will be given to functional selectivity (biased agonism and biased antagonism) in terms of mechanism of action and potential therapeutic application. The explosion of technology that has enabled observation of diverse 7TMR behavior has also shown how drugs can have multiple (pluridimensional) efficacies and how this can cause paradoxical drug classification and nomenclatures.
机译:将七个跨膜受体(7TMR)视为能够对多种结合伴侣进行变构反应的无序蛋白很有用。将7TMR视为变构系统,可以根据调节剂,导管(受体蛋白)和许多客人之间的能量流动来考虑亲和力和功效。这些客体可以是胞质溶胶中的其他分子,受体,膜结合蛋白或信号蛋白。这些能量的矢量流可以产生标准的规范来宾变构(药物作用的变构修饰),沿细胞膜平面的作用(受体寡聚)或定向到细胞质中的作用(作为功能选择性的差异信号)。这篇综述从分子动力学和蛋白质集合论的角度讨论了这些明显不同的药理作用,这倾向于统一7TMR对细胞的行为。就作用机理和潜在的治疗应用而言,将特别考虑功能选择性(偏向激动作用和偏向拮抗作用)。能够观察到多种多样的7TMR行为的技术爆炸也表明了药物如何具有多重(多维度)功效,以及这如何引起矛盾的药物分类和命名。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号